From chronic to curable: Twice-yearly shot shows near-total HIV eradication
Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.
First for Women on MSN31m
A Thunderclap Headache Sent This FIRST Editor to the ER—What Women Need To Know
I’m not someone who historically suffers from headaches. So I was shocked when I ended up in the ER recently with a ...